스마트 인슐린 펜 시장 : 접속 유형, 적응증, 유통 채널별, 세계 예측(2024-2032년)

Global Smart Insulin Pens Market size will grow at a 9.2% CAGR from 2024 to 2032, fueled by the rising adoption of advanced diabetes management technologies and increasing awareness of the advantages of smart pens. With a focus on enhancing diabetes care, these pens offer user-friendly features and improved treatment adherence. Their appeal lies in their convenient insulin delivery and automated dosage adjustments based on blood sugar levels. As patients and healthcare providers recognize these benefits, the smart insulin pens industry will expand significantly, driving innovation and accessibility in diabetes management.

For instance, in December 2023, Tandem Diabetes Care introduced the t: slim X2 smart insulin pen, designed to connect with a CGM for automatic insulin delivery based on blood sugar levels.

The smart insulin pens industry is segmented based on connectivity type, indication, distribution channel, and region.

The type 2 diabetes segment will establish a substantial foothold by 2032, attributed to the rising incidence of type 2 diabetes globally, particularly in developed nations where sedentary lifestyles and unhealthy diets are prevalent. Smart insulin pens offer convenience and precise insulin delivery, appealing to the needs of type 2 diabetes patients for effective self-management. With a growing focus on personalized healthcare and the increasing use of digital health solutions, the type 2 diabetes segment will stand as a key driver in the smart insulin pens industry.

The retail pharmacies segment will garner a sizeable smart insulin pens market share by 2032, primarily due to the convenience and accessibility these pharmacies offer to patients seeking diabetes management solutions. With a growing trend toward self-administration and monitoring of insulin, retail pharmacies play a pivotal role in distributing smart insulin pens to a broad consumer base. This increased availability, in line with rising awareness about the benefits of smart insulin pens, will position the retail pharmacies segment as a key driver behind market growth and expansion.

Asia Pacific smart insulin pens market will record a noteworthy CAGR by 2032, propelled by factors such as the rising prevalence of diabetes, increasing adoption of advanced healthcare technologies, and the region's expanding healthcare infrastructure. Countries like China, India, and Japan are at the forefront of embracing innovative solutions for diabetes management. With a strong focus on technological advancements and a growing demand for efficient healthcare solutions, Asia Pacific will emerge as a key contributor to the burgeoning smart insulin pens market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast calculations
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of diabetes
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Enhanced awareness of self-management of diabetes
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of smart insulin pens
• 3.3 Growth potential analysis
• 3.4 Porter's analysis
  • 3.4.1 Supplier power
  • 3.4.2 Buyer power
  • 3.4.3 Threat of new entrants
  • 3.4.4 Threat of substitutes
  • 3.4.5 Industry rivalry
• 3.5 PESTEL analysis
• 3.6 Reimbursement scenario
• 3.7 Regulatory landscape
• 3.8 Technological landscape
• 3.9 Future market trends
• 3.10 GAP analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Connectivity Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Bluetooth
• 5.3 NFC

Chapter 6 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Type 1 diabetes
• 6.3 Type 2 diabetes

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospital pharmacies
• 7.3 Retail pharmacies
• 7.4 E-commerce

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Cambridge Consultants Ltd.
• 9.2 Eli Lilly and Company
• 9.3 Emperra GmbH
• 9.4 Jiangsu Delfu medical device Co., Ltd.
• 9.5 Medtronic plc
• 9.6 Novo Nordisk
• 9.7 Ypsomed Group